November 15, 2021

Vingroup collaborates with Arcturus Therapeutics to establish a manufacturing facility in Vietnam for Arcturus’ mRNA Covid-19 vaccine

HANOI, VIETNAM –News Direct– Vingroup

HANOI, VIETNAM – Media OutReach – 2 August 2021 – Supported by the Vietnamese Government and Health Ministry, Vingroup (HOSE: VIC) and Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) announced a contract regarding a collaboration to establish a manufacturing facility in Vietnam for the manufacture of Arcturus’ mRNA COVID-19 vaccine candidate for sales and use in Vietnam. With a planned capacity of up to 200 million doses per year, Vingroup is expected to produce its first batches of the COVID-19 vaccine in early 2022.

Arcturus Therapeutics is a leading clinical stage company focused on messenger RNA (mRNA) medicines – one of the most advanced medicinal technologies in the world. Under the terms of the arrangement, VinBioCare – a member of Vingroup – will, with consultation from Arcturus, build out a manufacturing facility in Vietnam;…

Read full article here: